NEXTCURE, INC Stock-Based Compensation
NEXTCURE, INC (NXTC) reported Stock-Based Compensation of $648.00 thousand for the 6-month period ending 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-18
- NEXTCURE, INC share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $304.00K, a 48.30% decline year-over-year.
- NEXTCURE, INC share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $344.00K, a 74.76% decline year-over-year.
- NEXTCURE, INC share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $435.00K, a 71.36% decline year-over-year.
- NEXTCURE, INC share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $600.00K, a 60.76% decline year-over-year.
- NEXTCURE, INC share-based payment arrangement, noncash expense for fiscal 2023 was $8.19M, a 13.88% decline from fiscal 2022.
- NEXTCURE, INC share-based payment arrangement, noncash expense for fiscal 2022 was $9.51M, a 7.58% decline from fiscal 2021.
- NEXTCURE, INC share-based payment arrangement, noncash expense for fiscal 2021 was $10.29M, a 30.05% increase from fiscal 2020.
- NEXTCURE, INC share-based payment arrangement, noncash expense for fiscal 2020 was $7.91M, a 319.46% increase from fiscal 2019.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $304.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-08-18 | $648.00K S-4 · filed 2026-08-18 | $1.08M derived: sum of 3 quarters · filed 2026-08-18 | $1.68M derived: sum of 4 quarters · filed 2026-08-18 |
| 2026-03-31 | $344.00K 10-Q · filed 2026-05-07 | $779.00K derived: sum of 2 quarters · filed 2026-08-18 | $1.38M derived: sum of 3 quarters · filed 2026-08-18 | $1.97M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-12-31 | $435.00K derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | $1.03M derived: sum of 2 quarters · filed 2026-08-18 | $1.62M derived: sum of 3 quarters · filed 2026-08-18 | $2.99M S-4 · filed 2026-08-18 |
| 2025-09-30 | $600.00K derived: 10-Q 9 month − S-4 6 month · filed 2025-11-05 | $1.19M derived: sum of 2 quarters · filed 2026-08-18 | $2.55M 10-Q · filed 2025-11-05 | $4.07M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-06-30 | $588.00K derived: S-4 6 month − 10-Q 3 month · filed 2026-08-18 | $1.95M S-4 · filed 2026-08-18 | $3.47M derived: sum of 3 quarters · filed 2026-08-18 | $5.00M derived: sum of 4 quarters · filed 2026-08-18 |
| 2025-03-31 | $1.36M 10-Q · filed 2026-05-07 | $2.88M derived: sum of 2 quarters · filed 2026-08-18 | $4.41M derived: sum of 3 quarters · filed 2026-08-18 | $6.00M derived: sum of 4 quarters · filed 2026-08-18 |
| 2024-12-31 | $1.52M derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | $3.05M derived: sum of 2 quarters · filed 2026-08-18 | $4.64M derived: sum of 3 quarters · filed 2026-08-18 | $6.33M S-4 · filed 2026-08-18 |
| 2024-09-30 | $1.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.12M derived: sum of 2 quarters · filed 2025-11-05 | $4.82M 10-Q · filed 2025-11-05 | $6.80M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $3.29M 10-Q · filed 2025-08-07 | $5.27M derived: sum of 3 quarters · filed 2025-08-07 | $7.27M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.69M 10-Q · filed 2025-05-01 | $3.68M derived: sum of 2 quarters · filed 2025-05-01 | $5.68M derived: sum of 3 quarters · filed 2025-05-01 | $7.80M derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $3.98M derived: sum of 2 quarters · filed 2025-03-06 | $6.11M derived: sum of 3 quarters · filed 2025-03-06 | $8.19M 10-K · filed 2025-03-06 |
| 2023-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $4.13M derived: sum of 2 quarters · filed 2024-11-07 | $6.20M 10-Q · filed 2024-11-07 | $8.53M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $2.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $4.20M 10-Q · filed 2024-08-01 | $6.53M derived: sum of 3 quarters · filed 2024-08-01 | $8.84M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $2.08M 10-Q · filed 2024-05-02 | $4.40M derived: sum of 2 quarters · filed 2024-05-02 | $6.72M derived: sum of 3 quarters · filed 2024-05-02 | $8.96M derived: sum of 4 quarters · filed 2024-05-02 |
| 2022-12-31 | $2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $4.64M derived: sum of 2 quarters · filed 2024-03-21 | $6.88M derived: sum of 3 quarters · filed 2024-03-21 | $9.51M 10-K · filed 2024-03-21 |
| 2022-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $4.55M derived: sum of 2 quarters · filed 2023-11-02 | $7.18M 10-Q · filed 2023-11-02 | $9.69M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.87M 10-Q · filed 2023-08-03 | $7.38M derived: sum of 3 quarters · filed 2023-08-03 | $9.86M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $2.63M 10-Q · filed 2023-05-04 | $5.14M derived: sum of 2 quarters · filed 2023-05-04 | $7.62M derived: sum of 3 quarters · filed 2023-05-04 | $10.41M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $4.99M derived: sum of 2 quarters · filed 2023-03-02 | $7.78M derived: sum of 3 quarters · filed 2023-03-02 | $10.29M 10-K · filed 2023-03-02 |
| 2021-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $5.27M derived: sum of 2 quarters · filed 2022-11-03 | $7.78M 10-Q · filed 2022-11-03 | $10.12M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $5.29M 10-Q · filed 2022-08-04 | $7.64M derived: sum of 3 quarters · filed 2022-08-04 | $10.01M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $2.51M 10-Q · filed 2022-05-05 | $4.85M derived: sum of 2 quarters · filed 2022-05-05 | $7.22M derived: sum of 3 quarters · filed 2022-05-05 | $9.41M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $4.72M derived: sum of 2 quarters · filed 2022-03-03 | $6.90M derived: sum of 3 quarters · filed 2022-03-03 | $7.91M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $4.56M derived: sum of 2 quarters · filed 2021-11-04 | $5.57M 10-Q · filed 2021-11-04 | $6.13M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $3.19M 10-Q · filed 2021-08-05 | $3.76M derived: sum of 3 quarters · filed 2021-08-05 | $4.29M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $1.01M 10-Q · filed 2021-05-06 | $1.57M derived: sum of 2 quarters · filed 2021-05-06 | $2.10M derived: sum of 3 quarters · filed 2021-05-06 | $2.51M derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $567.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $1.09M derived: sum of 2 quarters · filed 2021-03-04 | $1.50M derived: sum of 3 quarters · filed 2021-03-04 | $1.89M 10-K · filed 2021-03-04 |
| 2019-09-30 | $524.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $936.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.32M 10-Q · filed 2020-11-05 | $1.44M derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $795.00K 10-Q · filed 2020-08-06 | $920.00K derived: sum of 3 quarters · filed 2020-08-06 | $1.01M derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $383.00K 10-Q · filed 2020-05-07 | $508.00K derived: sum of 2 quarters · filed 2020-05-07 | $598.00K derived: sum of 3 quarters · filed 2020-05-07 | $622.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $125.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $215.00K derived: sum of 2 quarters · filed 2020-03-12 | $239.00K derived: sum of 3 quarters · filed 2020-03-12 | $263.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $90.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $114.00K derived: sum of 2 quarters · filed 2019-11-12 | $138.00K 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $48.00K 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $24.00K 10-Q · filed 2019-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |